Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose amoxicillin-based regimens for Helicobacter pylori eradication
ChiCTR2100045778Phase 4Recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin, vonoprazan, esomeprazole, clarithromycin and bismuth subsalicylate in Helicobacter pylori infection (6 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Eradication rate. Started Apr 2021; status: recruiting.
02
Drugs
amoxicillinvonoprazanesomeprazoleclarithromycinbismuth subsalicylate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2100045778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045778.